Bone-healing pattern on critical-sized defects treated by rhPTH

Journal of Hard Tissue Biology

Volumn 21, Issue 4, 2012, Pages 443-450

  Jammal, María V ^a,b   Pastorino, Nina F ^a   Abate, Carlos M ^b   Takagi, Shin ^c   Nagatsuka, Hitoshi ^c   Missana, Liliana R ^a,b  

^a UNIVERSIDAD NACIONAL DE TUCUMÁN   (Argentina)

^b PLANTA PILOTO DE PROCESOS INDUSTRIALES MICROBIOLÓGICOS PROIMI CONICET   (Argentina)

^c OKAYAMA UNIVERSITY   (Japan)

Author keywords

Bone hyperostosis; Bone regeneration; Critical sized defect; Proliferative bone lesions; rhPTH

Indexed keywords

RATTUS; RATTUS NORVEGICUS;

EID: 84870798968     PISSN: 13417649     EISSN: None     Source Type: Journal    
DOI: 10.2485/jhtb.21.443     Document Type: Article

References (25)

1. Bilezikian J, Rubin M. and Finkelstein, J. Parathyroid hormone as an anabolic therapy for women and men. Journal of Endocrinological Investigation 28: 41-49. 2005
2. Pettway G, Megank J, Koh A, Feller E, Goldstein S and McCauley L. Parathyroid hormone mediates bone growth through the regulation of osteoblast proliferation and differentiation. Bone 42: 806-818. 2008
3. Dobnig H and Turner R. Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells. Endocrinology 136: 3632-3638. 1995
4. Onyia J, Bidwell J, Herring J, Hulman J and Hock J. In vivo, human parathyroid hormone fragment (hPTH 1-34) transiently stimulates immediate early response gene expression, but not proliferation, in trabecular bone cells of young rats. Bone 17: 479-484. 1995
5. Centrella, M., McCarthy, T., and Canalis, E. Parathyroid hormone modulates transforming growth factor beta activity and binding in osteoblast-enriched cell cultures from fetal rat parietal bone. Proceedings of the National Academy of Sciences of the United States of America 85: 5889-5893. 1988
6. Bikle D and Wang Y. Insulin like growth factor-I: a critical mediator of the skeletal response to parathyroid tormone. Current Molecular Pharmacology Jun 25. [Epub ahead of print]. 2011
7. Hu Z, Niu H, Yang X, Li H, Sang G and Li B. Recombinant parathyroid hormone 1-34: pharmacokinetics, tissue distribution and excretion in rats. International Journal of Pharmaceutics 317: 144-154. 2006
8. Hodsman A, Bauer D, Dempster D, Dian L, Harris S, Kendler D, McClung M, Miller P, Olszynski W, Orwoll E. and Yuen C.K. Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use. Endocrine Reviews 26: 688-703. (2005)
9. Nozaka K, Miyakoshi N, Kasukawa Y, Maekawa S, Noguchi H and Shimada Y. Intermittent administration of human parathyroid hormone enhances bone formation and union at the site of cancellous bone osteotomy in normal and ovariectomized rats. Bone 42: 90-97. 2008
10. Komatsu D, Brune K, Liu H, Schmidt A, Han B, Zeng Q, Yang X, Nunes J, Lu Y, Geiser A, Ma Y, Wolos J, Westmore M and Sato M. Longitudinal in vivo analysis of the region- specific efficacy of parathyroid hormone in a rat cortical defect model. Endocrinology 150: 1570-1579. 2009
11. Schmitz J P and Hollinger J O. The critical size defect as an experimental model for craniomandibular nonunions. Clinical Orthopaedics and Related Research 205: 299-308. 1986
12. Aybar A, Territoriale E. and Missana L. Animal model in calvaria to evaluate bone strategies. Acta Odontológica Latinoamericana 18: 21-25. 2005
13. Andreassen T and Cacciafesta V. Intermittent parathyroid hormone treatment enhances guided bone regeneration in rat calvarial bone defects. Journal of Craniofacial Surgery 15: 424-427. 2004
14. Yun J, Wikesjö U, Borke J, Bisch F, Lewis J, Herold R, Swiec G, Wood J and McPherson J. Effect of systemic parathyroid hormone (1-34) and a beta-tricalcium phosphate biomaterial on local bone formation in a critical-size rat calvarial defect model. Journal of Clinical Periodontology 37: 419-426. 2010
15. Vahle J, Sato M., Long G, Young J, Francis P, Engelhardt J, Westmore M, Linda Y. and Nold J. Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1-34) for 2 years and relevance to human safety. Toxicologic Pathology 30: 312-321. 2002
16. Jammal M, Territoriale E, Abate C and Missana L. High resolution films for bone regeneration evaluation. Acta Odontológica Latinoamericana 23: 33-36.
17. Long P, Leininge J, Nold J and Lieuallen W. Proliferative lesions of bone, cartilage, tooth and synovium in Rats. MST-2. In: Guides for toxicologic pathology. Washington, DC: STP/ARP/ AFIP, 1993 p. 1-3.
18. Vahle J, Long G, Sandusky G, Westmore M, Ma L and Sato M. Bone neoplasms in F344 rats given teriparatide (rhPTH 1-34) are dependent on duration of treatment and dose. Toxicologic Pathology 32: 426-438. 2004
19. Jilka R. (2007) Molecular and cellular mechanism of the anabolic effect of intermittent PTH. Bone 40: 1434-1446. 2010
20. Friedenstein AJ. Determined and inducible osteogenic precursor cells. In: Hand tissue growth repair and remineralization. Ciba Foundation Symposium. New series 11, 1973 p. 169-185.
21. Özcelik D, Turan T, Kabukcuoglu F, Ugurlu K, Ozturk O, Basak M and Bankaoglu, M. Bone induction capacity of the periosteum and neonatal dura in the setting of the rat zygomatic arch fracture model. Archives of Facial Plastic Surgery 5: 301-308. 2003
22. Jollette J, Wilker C, Smith S, Doyle N, Hardisty J, Metcalfe A, Marriott T, Fox J and Wells D. Defining a noncarcinogenic dose of recombinant human parathyroid hormone 1-84 in a 2-year study in Fischer 344 rats. Toxicologic Pathology 34: 929-940. 2006
23. Zatloukal K, French S, Stumptner C, Strnad P, Harada M, Toivola D, Cadrin M and Bishr Omary M. From Mallory to Mallory-Denk bodies: what, how and why? Experimental Cell Research 313: 2033-2049. 2007
24. Harada M. Autophagy is involved in the elimination of intracellular inclusions, Mallory-Denk bodies in hepatocytes. type=journal>Medical Molecular Morphology 43: 13-18.2010
25. Kroemer G, Galluzzi L, Vandenabeele P, Abrams J, Alnemri E, Baehrecke E, Blagosklonny M, El-Deiry W, Golstein P, Green D, Hengartner M, Knight R, Kumar S, Lipton S, Malorni W, Nuñez G, Peter M, Tschopp J, Yuan J, Piacentini M, Zhivotovsky B and Melino G. Classification of cell death: Recommendations of the Nomenclature Committee on Cell Death. Cell Death & Differentiation 16: 3-11. 2009